Citation: Cr. Messick et al., IN-VITRO ACTIVITY OF RPR-106972 ALONE AND IN COMBINATION WITH VANCOMYCIN, AMPICILLIN, AND GENTAMICIN AGAINST MULTIDRUG-RESISTANT ENTEROCOCCI, Diagnostic microbiology and infectious disease, 32(2), 1998, pp. 95-99
Citation: Sj. Martin et Sl. Pendland, BACTERICIDAL ACTIVITY AND POSTANTIBIOTIC EFFECT OF CLARITHROMYCIN AND14-HYDROXYCLARITHROMYCIN, ALONE AND IN COMBINATION, AGAINST LEGIONELLA-PNEUMOPHILA, Journal of antimicrobial chemotherapy, 41(6), 1998, pp. 643-648
Authors:
MARTIN SJ
PENDLAND SL
CHEN C
SCHRECKENBERGER PC
DANZIGER LH
Citation: Sj. Martin et al., IN-VITRO ACTIVITY OF CLARITHROMYCIN ALONE AND IN COMBINATION WITH CIPROFLOXACIN OR LEVOFLOXACIN AGAINST LEGIONELLA SPP - ENHANCED EFFECT BYTHE ADDITION OF THE METABOLITE 14-HYDROXY CLARITHROMYCIN, Diagnostic microbiology and infectious disease, 29(3), 1997, pp. 167-171
Citation: Cr. Messick et Sl. Pendland, IN-VITRO ACTIVITY OF CHLORAMPHENICOL ALONE AND IN COMBINATION WITH VANCOMYCIN, AMPICILLIN, OR RP-59500 (QUINUPRISTIN DALFOPRISTIN) AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI/, Diagnostic microbiology and infectious disease, 29(3), 1997, pp. 203-205
Authors:
PENDLAND SL
KILLIAN AD
WOODWARD JG
RODVOLD KA
Citation: Sl. Pendland et al., IN-VITRO ACTIVITY OF A NEW ORAL STREPTOGRAMIN, RPR-106972, ALONE AND IN COMBINATION WITH RIFAMPICIN OR CIPROFLOXACIN AGAINST LEGIONELLA SPP, Journal of antimicrobial chemotherapy, 39(5), 1997, pp. 651-653
Authors:
FISCELLA RG
MOSHIFAR M
MESSICK CR
PENDLAND SL
CHANDLER JW
VIANA M
Citation: Rg. Fiscella et al., POLYHEXAMETHYLENE BIGUANIDE (PHMB) IN THE TREATMENT OF EXPERIMENTAL FUSARIUM KERATOMYCOSIS, Cornea, 16(4), 1997, pp. 447-449
Authors:
PENDLAND SL
MARTIN SJ
CHEN C
SCHRECKENBERGER PC
DANZIGER LH
Citation: Sl. Pendland et al., COMPARISON OF CHARCOAL-BASED AND STARCH-BASED MEDIA FOR TESTING SUSCEPTIBILITIES OF LEGIONELLA SPECIES TO MACROLIDES, AZALIDES, AND FLUOROQUINOLONES, Journal of clinical microbiology, 35(11), 1997, pp. 3004-3006
Citation: Jm. Meyer et al., IN-VITRO SYNERGY TESTING OF CLARITHROMYCIN AND 14-HYDROXYCLARITHROMYCIN WITH AMOXICILLIN OR BISMUTH SUBSALICYLATE AGAINST HELICOBACTER-PYLORI, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1607-1608
Authors:
OCCHIPINTI DJ
PENDLAND SL
SCHOONOVER LL
RYPINS EB
DANZIGER LH
RODVOLD KA
Citation: Dj. Occhipinti et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 MULTIPLE-DOSE PIPERACILLIN-TAZOBACTAM REGIMENS, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2511-2517
Authors:
MEYER JM
RYU S
PENDLAND SL
KANYOK TP
DANZIGER LH
Citation: Jm. Meyer et al., IN-VITRO SYNERGY TESTING OF AMINOSIDINE (AMS) WITH METRONIDAZOLE ALONE (M) OR METRONIDAZOLE PLUS HYDROXYMETRONIDAZOLE (HM) AGAINST HELICOBACTER-PYLORI, Gastroenterology, 112(4), 1997, pp. 1041-1041
Authors:
MARTIN SJ
PENDLAND SL
CHEN C
SCHRECKENBERGER P
DANZIGER LH
Citation: Sj. Martin et al., IN-VITRO SYNERGY TESTING OF MACROLIDE QUINOLONE COMBINATIONS AGAINST 41 CLINICAL ISOLATES OF LEGIONELLA, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1419-1421
Citation: Lh. Danziger et Sl. Pendland, BACTERIAL-RESISTANCE TO BETA-LACTAM ANTIBIOTICS, American journal of health-system pharmacy, 52(6), 1995, pp. 3-8
Authors:
PENDLAND SL
PISCITELLI SC
SCHRECKENBERGER PC
DANZIGER LH
Citation: Sl. Pendland et al., IN-VITRO ACTIVITIES OF METRONIDAZOLE AND ITS HYDROXY METABOLITE AGAINST BACTEROIDES SPP, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2106-2110